RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 13.38
0.00 (0.00%)
Mar 6, 2026, 8:00 AM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 8.3 million as of March 6, 2026. Its market cap has increased by 4.90% in one year.
Market Cap
8.30M
Enterprise Value
5.89M
Revenue
4.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.38
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 8.30M, a decrease of -65.16%. That is a compound annual growth rate of -3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 8.30M | -4.46% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.59B |
| GSK plc | 85.07B |
| Haleon | 34.64B |
| Smith & Nephew | 11.35B |
| Oxford BioDynamics | 10.73M |
| genedrive | 10.55M |
| Genflow Biosciences | 9.38M |
| Verici Dx | 8.70M |